The National Investor

Here, we catch up for the first time in 2026 with Mike Stark, C.E.O. of Arizona Gold & Silver Corp.

AZS' Philadelphia Project is one of the more unique and compelling geological stories we've ever covered. And as you'll hear yet again in this quick update, what's being revealed through the exploration work and assay results to date have already well exceeded the initial, working model of this prospective massive ore body which, in the end, could hold a several million ounce gold (primary) resource.

LINKS:

AZS' website -- https://arizonagoldsilver.com/

The Phiadelphia Project's specific page (LOTS of background, graphics and more here!) -- https://arizonagoldsilver.com/philadelphia/

Mike Stark's 2025 Christmas / Year end report to shareholders -- https://arizonagoldsilver.com/2025-letter-to-shareholders/

The big new financial soap opera surrounds this weekend's news of the federal criminal investigation into the Federal Reserve and, specifically, Chairman Jerome Powell.

That move is unprecedented; as was Powell's blunt response last evening.

Here--acknowledging the initial, knee-jerk reactions to Trump as either a modern-day anti-banker Andy Jackson OR an Emperor Nero-like thug and crackpot by many--Yours truly as usual covers this with MATH and FACTS.

And among the possible outcomes I discuss, Trump may have made it more likely than not that Jerome Powell actually STAYS in his present post past May!

We're revisiting copper plays in our portfolio/universe currently, given the red metal's recent record prices...and here, we couldn't come up with a more game-changing story if we tried!

As I discuss here with Gunnison's C.F.O. and Senior V.P. Craig Hallworth, Gunnison announced in December some of the biggest news in the U.S. Mining industry in YEARS: And that was the first U.S. production of copper EVER using the new Nuton technology developed by partner Rio Tinto at Gunnison's Johnson Camp Mine in Arizona.

This removes the need for traditional smelting; and is now the first modern example of raw copper-containing ores being mined, processed and turned into FINISHED COPPER all within the U.S. of A.!

This is but one reason we see Gunnison's shares as absurdly undervalued.

Elsewhere, the company will shortly be putting out an updated P.E.A. (Preliminary Economic Assessment) on its flagship and much larger Gunnison Copper Project; that as well is an exciting story about how, in total, the company before long could be kicking out nearly a quarter of a billion pounds of copper annually!

LINKS:

Gunnison's web site -- https://www.gunnisoncopper.com/

Company press releases -- https://www.gunnisoncopper.com/news/news-2025

Nuton, LLC -- https://nuton.tech/

A good Morningstar story on copper dynamics -- https://www.morningstar.com/news/pr-newswire/20260108ny58962/substantial-shortfall-in-copper-supply-widens-as-the-race-for-ai-and-growing-defense-spending-add-to-accelerating-demand-new-sp-global-study-finds

An interview with billionaire investor and mining industry legend Robert Friedland -- https://robertsinn.substack.com/p/billionaire-investor-robert-friedland

Here, C.E.O. Robin Dow joins me to go over the Monday, Jan. 5 news release totaling up assay results from all six holes of the recent Murdock Mountain, Nevada drillign program.

In short: Success at defining both the structure expected as well as the widths/grade of potentially economic P2O5 (phopshate).

VERY exciting news as Dow and team check a couple more boxes on this unique exploration thesis!

LINKS:

The full press release from yesterday (Jan. 5) outlining assay results and related news -- https://webfiles.thecse.com/260105_NOP_-_NR_Assay_Results.pdf?Bi_nDiv0RyZJrLZ_mUhgqjfchDy_pYyq

My prior full video profile of Nevada Organic Phosphate and its project -- https://webfiles.thecse.com/260105_NOP_-_NR_Assay_Results.pdf?Bi_nDiv0RyZJrLZ_mUhgqjfchDy_pYyq

In the first podcast of The New Year, I put off what I'd planned to present and necessarily go into this weekend's effective annexation of Venezuela by the Trump Administration.

Implications of a move that's actually been planned for YEARS (contrary to accusations by those with the Derangement strain of T.D.S. that this was an impulsive and reckless move by the president) are MANY, as I discuss:

-- What it all means for priorities on our own soil when it comes to energy and metals and what we THOUGHT we had in an "America First" policy

-- This was a MAJOR furtherance of "The Donroe Doctrine"

-- What, if anything, were Russia and China promised? And what might their responses be?

-- Implications for the 2026 mid-terms in November.

-- and MUCH more.

I also go into America's LONG history of such moves and explain why Trump's capture of Maduro and turning Venezuela into an overt "vassal" is actually, in a way, FAR more open and honest than what the Dulles brothers engaged in once upon a time!

LINKS:
"The Brothers" by Steven Kinzer -- Authoritative bio of sorts of John Foster Dulles and Allen Dulles I referred to. -- https://www.amazon.com/s?k=the+brothers+by+stephen+kinzer

Dr. Cristina Martin Jimenez post referred to on the back story of the Venezuela annexation/Maduro "arrest" -- https://x.com/crismartinj/status/2007791005626482701

Here, Dennis joins me to add some more color to the Year-end Shareholder Letter/recap BioLargo just sent out on the early morning of 12/29.

In order and approximate times we cover:

(After opening remarks) -- Calvert's role with the ETTAC Committee of the U.S. Department of Commerce, specifically on some recommendations just sent recently to Sec. Lutnick. (KEY here -- the Administration needs to be financially and otherwise proactive with American ingenuity/technlogies and not leave them solely to "market forces.")

-- 13:00 -- An update on the PFAS remediation work, highlighting the "finishing touches" ahead of launch in New Jersey and some follow-on expected contracts.

-- 25:30 -- An update on the company's energy subsidiary developing the Cellinity battery -- Dennis explains this battery technology's superior attributes, and especially how it better fills the major needs going forward for energy storage.

-- 34:30 -- More of a discussion in this interlude of how on more than one front BioLargo is looking to more tightly integrate w/ state and local governments, industrial development agencies and the like.

-- 46:15 -- The big revenue news expected near-term with the multi-step imminent launch of Clyra's products

-- 54:30 -- A recap of the Pooph! saga and potential next steps for the company to 1. protect its interests/collect on past business from its former partner and 2. Find a "Plan B" to monetize anew this demonstrably GREAT, proven technology.

LINKS:

-- BioLargo's just-released 2025 Shareholder letter and update -- https://feeds.issuerdirect.com/news-release.html?newsid=7448032311850076&symbol=BLGO

-- ETTAC's letter to Commerce Sec. Lutnick on "Strategic Policy Recommendations to Secure U.S. Leadership in Next-Generation
Industrial & Resource Technologies" -- https://www.trade.gov/sites/default/files/2025-12/ETTAC%202025-2026%20Rec%206%20Strategic%20Policy%20for%20Next-Gen%20Tech%20508c.pdf

-- ETTAC's home page for more info -- https://www.trade.gov/ettac

-- Our previous video on Clyra's advancements as mentioned -- https://www.youtube.com/watch?v=Zp1VRjV6Btg

-- BioLargo and its subsidiaries' visionary development/collaboration partner, 22nd Century by Design -- https://www.22ndcenturybydesign.com/

-- BioLargo's home page: https://www.biolargo.com/

(NOTE: Under "About BioLargo as well as elsewhere you will find dedicated links to likewise very comprehensive websites for each subsidiary company!)

Here, I unpackage with George Integra's substantial strides -- and about a 500% share price increase -- of the last year!

After discussing the overall healthy macro environment for gold (primarily) and silver as well as the FAR improved permitting and policy environment under Trump 2.0, we go into the company's key components/stories:

--- The MASSIVE jump in cash flow and earnings from Florida Canyon, acquired in late 2024. The surge in the gold price has caused financial metrics to soar beyond expectations, contributing to Integra's financial rsults AND paving the way for more and faster development elsewhere.

--- Just days before this discussion, the company released its Feasibility Study on the DeLamar Project in SW ID, another of its Great Basin properties. As you'll hear, economics and the "game plan" here are greatly enhanced over the prior "snap shot" and, in part, have prompted most of the analysts following Integra to significantly raise their price targets.

--- At both DeLamar and Nevada North, the greater cash flow from Florida Canyon will speed up the process of Integra becomign a more substantial intermediate producer, with an industry-leading cost profile.


LINKS:

Integra's web site - https://integraresources.com/

The recent Feasibility Study on DeLamar specifically - https://integraresources.com/investors/events/ (NOTE: The most recent Q3 webinar, also referred to here, can be found on this page.)

Here, Chris addresses the economic, tariff/trade, debt, markets, investment sector, political and other aspects of the concluding 2025 first year of Trump 2.0 against his theme for the year "Let's Do The Math."

LINKS MENTIONED:

Paul Volcker's Forgotten Legacy -- https://www.theepochtimes.com/business/the-forgotten-legacy-of-paul-volcker-4204594

A recent Podcaster News Podcast following the December Fed meeting which gave us the expected "Hawkish rate cut" and the UNEXPECTED additon of a new Q.E. program and more to shore up markets -- https://www.youtube.com/watch?v=lNIoLOQGRFM (NOTE: This complements the present YMT episode with more market, investment sector and related comments.)

In one of a couple currently discussed stories of ours we've been patient with, appearances are growing that GT Biopharma is "coming back from the dead."

As C.E.O. Breen explains, GT Biopharma is on a quest to improve cancer care and come up with modern remedies for an industry that is still relying on much the same "barbaric" regimens (essentially, "cut and burn") employed for some 80 years now. As we discuss, its platform technology suggests, together with some early clinical success, that the company has the goods!

Further, it now has sufficient backing from a couple key investors to continue with key clinical trials for the foreseeable future on its patented immunotherapy platform for the treatment of cancer, developed by world renown scientist Dr. Jeffrey Miller from the Univ. of Minnesota.

As I've stressed with other speculative stories recently -- both in advising our Members to leave some for a while and also embrace a few new "fresh" stories -- GT Biopharma has great potential to move the needle (and its sub-$10 million market cap presently) within MONTHS as opposed to years.

Do your due diligence here...I'm confident you'll come away as excited about this risk-reward setup as is possible with pretty much ANY kind of company!